Literature DB >> 19526283

Role of Tat protein in HIV neuropathogenesis.

Wenxue Li1, Guanhan Li, Joseph Steiner, Avindra Nath.   

Abstract

The Tat protein of the human immunodeficiency virus (HIV) has been implicated in the pathophysiology of the neurocognitive deficits associated with HIV infection. This is the earliest protein to be produced by the proviral DNA in the infected cell. The protein not only drives the regulatory regions of the virus but may also be actively released from the cell and then interact with the cell surface receptors of other uninfected cells in the brain leading to cellular dysfunction. It may also be taken up by these cells and can then activate a number of host genes. The Tat protein is highly potent and has the unique ability to travel along neuronal pathways. Importantly, its production is not impacted by the use of antiretroviral drugs once the proviral DNA has been formed. This article reviews the pleomorphic actions of Tat protein and the evidence supporting its central role in the neuropathogenesis of the HIV infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19526283     DOI: 10.1007/s12640-009-9047-8

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  188 in total

1.  HIV-TAT protein upregulates expression of multidrug resistance protein 1 in the blood-brain barrier.

Authors:  Kentaro Hayashi; Hong Pu; Ibolya E Andras; Sung Yong Eum; Atsushi Yamauchi; Bernhard Hennig; Michal Toborek
Journal:  J Cereb Blood Flow Metab       Date:  2005-12-14       Impact factor: 6.200

2.  Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues.

Authors:  L Hudson; J Liu; A Nath; M Jones; R Raghavan; O Narayan; D Male; I Everall
Journal:  J Neurovirol       Date:  2000-04       Impact factor: 2.643

3.  HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region.

Authors:  H C Chang; F Samaniego; B C Nair; L Buonaguro; B Ensoli
Journal:  AIDS       Date:  1997-10       Impact factor: 4.177

4.  Human immunodeficiency virus-1 protein tat and methamphetamine interactions.

Authors:  Shaji Theodore; Stephanie Stolberg; Wayne A Cass; William F Maragos
Journal:  Ann N Y Acad Sci       Date:  2006-08       Impact factor: 5.691

5.  Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins.

Authors:  Antonio Fittipaldi; Aldo Ferrari; Monica Zoppé; Caterina Arcangeli; Vittorio Pellegrini; Fabio Beltram; Mauro Giacca
Journal:  J Biol Chem       Date:  2003-05-27       Impact factor: 5.157

6.  HIV-1 Tat induces neuronal death via tumor necrosis factor-alpha and activation of non-N-methyl-D-aspartate receptors by a NFkappaB-independent mechanism.

Authors:  D R New; S B Maggirwar; L G Epstein; S Dewhurst; H A Gelbard
Journal:  J Biol Chem       Date:  1998-07-10       Impact factor: 5.157

7.  HIV-tat induces formation of an LRP-PSD-95- NMDAR-nNOS complex that promotes apoptosis in neurons and astrocytes.

Authors:  Eliseo A Eugenin; Jessie E King; Avindra Nath; Tina M Calderon; R Suzanne Zukin; Michael V L Bennett; Joan W Berman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-21       Impact factor: 11.205

8.  PPARalpha and PPARgamma effectively protect against HIV-induced inflammatory responses in brain endothelial cells.

Authors:  Wen Huang; Geun Bae Rha; Min-Joon Han; Sung Yong Eum; Ibolya E András; Yu Zhong; Bernhard Hennig; Michal Toborek
Journal:  J Neurochem       Date:  2008-08-14       Impact factor: 5.372

9.  Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement.

Authors:  M Jones; K Olafson; M R Del Bigio; J Peeling; A Nath
Journal:  J Neuropathol Exp Neurol       Date:  1998-06       Impact factor: 3.685

10.  Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain.

Authors:  Govinder Flora; Yong Woo Lee; Avindra Nath; Bernhard Hennig; William Maragos; Michal Toborek
Journal:  Exp Neurol       Date:  2003-01       Impact factor: 5.330

View more
  96 in total

1.  Propionibacterium acnes brain abscess in a patient with HIV-1 infection.

Authors:  Jennifer L Lyons; Patricia D Scripko; Shibani S Mukerji; Oluwole Awosika; Wun-Ju Shieh; Sherif Zaki; Marlene DeLeon-Carnes; Christopher Taylor; Dan Milner; Jennifer A Johnson; Joshua P Klein
Journal:  J Neurovirol       Date:  2012-03-09       Impact factor: 2.643

Review 2.  Neurotoxicity of human immunodeficiency virus-1: viral proteins and axonal transport.

Authors:  Italo Mocchetti; Alessia Bachis; Valeriya Avdoshina
Journal:  Neurotox Res       Date:  2011-09-27       Impact factor: 3.911

3.  HIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naive Ugandan children.

Authors:  Michael J Boivin; Theodore D Ruel; Hannah E Boal; Paul Bangirana; Huyen Cao; Leigh A Eller; Edwin Charlebois; Diane V Havlir; Moses R Kamya; Jane Achan; Carolyne Akello; Joseph K Wong
Journal:  AIDS       Date:  2010-05-15       Impact factor: 4.177

4.  HIV-1 Tat protein promotes neuronal dysfunction through disruption of microRNAs.

Authors:  J Robert Chang; Ruma Mukerjee; Asen Bagashev; Luis Del Valle; Tinatin Chabrashvili; Brian J Hawkins; Johnny J He; Bassel E Sawaya
Journal:  J Biol Chem       Date:  2011-09-28       Impact factor: 5.157

5.  HIV-1 Tat activates a RhoA signaling pathway to reduce NMDA-evoked calcium responses in hippocampal neurons via an actin-dependent mechanism.

Authors:  Kelly A Krogh; Elizabeth Lyddon; Stanley A Thayer
Journal:  J Neurochem       Date:  2014-09-18       Impact factor: 5.372

6.  A GluN2B-Selective NMDAR Antagonist Reverses Synapse Loss and Cognitive Impairment Produced by the HIV-1 Protein Tat.

Authors:  Jonathan D Raybuck; Nicholas J Hargus; Stanley A Thayer
Journal:  J Neurosci       Date:  2017-07-17       Impact factor: 6.167

7.  Neuroprotective activity of pDING in response to HIV-1 Tat.

Authors:  Nune Darbinian; Kamel Khalili; Shohreh Amini
Journal:  J Cell Physiol       Date:  2014-02       Impact factor: 6.384

8.  Novel neuroprotective GSK-3β inhibitor restricts Tat-mediated HIV-1 replication.

Authors:  Irene Guendel; Sergey Iordanskiy; Rachel Van Duyne; Kylene Kehn-Hall; Mohammed Saifuddin; Ravi Das; Elizabeth Jaworski; Gavin C Sampey; Svetlana Senina; Leonard Shultz; Aarthi Narayanan; Hao Chen; Benjamin Lepene; Chen Zeng; Fatah Kashanchi
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

Review 9.  Cortical consequences of HIV-1 Tat exposure in rats are enhanced by chronic cocaine.

Authors:  Wesley N Wayman; Lihua Chen; Amanda L Persons; T Celeste Napier
Journal:  Curr HIV Res       Date:  2015       Impact factor: 1.581

Review 10.  Where does HIV hide? A focus on the central nervous system.

Authors:  Melissa Churchill; Avindra Nath
Journal:  Curr Opin HIV AIDS       Date:  2013-05       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.